Accord Healthcare Ltd will supply hydroxychloroquine to the COPCOV study. The trial will see if the anti-malarial can prevent doctors catching COVID-19.
Fox_Claire . Well, of course they are. Trump's solution of choice, but no evidence it works.
What were they waiting for?
Sanofi won't mind that 1 bit. They will get the credit and a huge boost.
Fox_Claire Make sure it’s not made in China.... CCP
hI? 'If ongoing clinical studies demonstrate its efficacy and safety, Sanofi will continue to donate the medicine.' by sanofi
Fox_Claire I hope they're giving some of it to lupus patients who can't get it now.
hydroxylchloroquinne has some adverse side effects
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: